Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONTAK in CTCL According to CD25 Status
NCT00211198Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2001
- Primary completion
- Jan 2005
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of denileukin diftitox in cutaneous T-cell lymphoma (CTCL), sponsored by Eisai Co., Ltd.. Started May 2001; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00211198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211198.